AAPL 189.07 +0.3 (+0.16%)MSFT 117.02 -0.72 (-0.62%)FB 167.35 +1.05 (+0.63%)ZNGA 5.3 -0.01 (-0.19%)NVDA 175.17 +1.31 (+0.75%)WBA 61.7 +0.14 (+0.23%)GOOG 1184.77 -8.35 (-0.70%)PIH 5.45 -0.16 (-2.85%)
AAPL 189.07 +0.3 (+0.16%)MSFT 117.02 -0.72 (-0.62%)FB 167.35 +1.05 (+0.63%)ZNGA 5.3 -0.01 (-0.19%)NVDA 175.17 +1.31 (+0.75%)WBA 61.7 +0.14 (+0.23%)GOOG 1184.77 -8.35 (-0.70%)PIH 5.45 -0.16 (-2.85%)

Financial Summary IFRX Quote InflaRx N.V

InflaRx N.V. Quote

InflaRx N.V. (IFRX)

40.53 -2.06 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol IFRX
Price 40.53
Beta -0.04
Vol Avg 66.13 K
Mkt cap 706.78 M
Shares 9
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -40.34% Strong Sell
ROA -38.71% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity 4.20% Neutral
P/E -15.20 Strong Sell
P/B 3.07 Strong Buy
Company Profile

CEO

Niels Riedemann

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.